San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

This revolution is being powered by RNA technology—and Canada is uniquely positioned to lead it. While the swift development ...

With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...